BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ampuero J, Romero-Gómez M. Assessing cardiovascular risk in hepatitis C: An unmet need. World J Hepatol 2015; 7(19): 2214-2219 [PMID: 26380047 DOI: 10.4254/wjh.v7.i19.2214]
URL: https://www.wjgnet.com/1948-5182/full/v7/i19/2214.htm
Number Citing Articles
1
M.F. Bassendine, S.U. Nielsen, S.H. Bridge, D.J. Felmlee, D.A. Sheridan, C.J. Packard, R.D. Neely. Hepatitis C virus and atherosclerosis: A legacy after virologic cure?Clinics and Research in Hepatology and Gastroenterology 2017; 41(1): 25 doi: 10.1016/j.clinre.2016.09.008
2
Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert. Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysisIndian Journal of Medical Research 2020; 152(6): 562 doi: 10.4103/ijmr.IJMR_1088_18
3
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid AtherosclerosisCardiology in Review 2021; 29(4): 178 doi: 10.1097/CRD.0000000000000314
4
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actualMedicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
5
Stefano GITTO, Carmela CURSARO, Alessandra BARTOLI, Marzia MARGOTTI, Pietro ANDREONE. Hepatitis C: clinical management and debated issuesMinerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07208-0
6
Dalia A Freekh, Maged W Helmy, Mohamed Said, Noha M El-khodary. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infectionSaudi Pharmaceutical Journal 2021; 29(10): 1120 doi: 10.1016/j.jsps.2021.08.006
7
Nicolas Musigk, Phillip Suwalski, Ainoosh Golpour, DeLisa Fairweather, Karin Klingel, Pilar Martin, Andrea Frustaci, Leslie T. Cooper, Thomas F. Lüscher, Ulf Landmesser, Bettina Heidecker. The inflammatory spectrum of cardiomyopathiesFrontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1251780
8
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
9
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current statusMedicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
10
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changesWorld Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
11
Victoria Aguilera, Tommaso Di Maira, Isabel Conde, Victoria Fornés-Ferrer, Carmen Vinaixa, Carmen Pallarés, Angela Carvalho-Gomes, Almudena Cubells, María García, Ángel Rubín, Salvador Benlloch, Luisa Gonzalez-Dieguez, Jose Miguel Molina, Lorena Puchades, F. Xavier López-Labrador, Martin Prieto, Marina Berenguer. Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective studyTransplant International 2018; 31(6): 649 doi: 10.1111/tri.13145
12
Rocío Muñoz-Hernández, Javier Ampuero, Raquel Millán, Antonio Gil-Gómez, Ángela Rojas, Hada C. Macher, Rocío Gallego-Durán, Sheila Gato, Rocío Montero-Vallejo, María C. Rico, Douglas Maya-Miles, Yolanda Sánchez-Torrijos, Isabel Carmona Soria, Pablo Stiefel, Manuel Romero-Gómez. Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR StudyClinical and Translational Gastroenterology 2020; 11(8): e00203 doi: 10.14309/ctg.0000000000000203
13
Ryo Fukuda, Yasuteru Kondo. Hepatitis C virus infection could affect the pathogenesis of ischemic heart diseases in northern JapanHepatology Research 2019; 49(3): 355 doi: 10.1111/hepr.13283
14
Adauto CASTELO, Carlos Eduardo BRANDÃO MELLO, Rosangela TEIXEIRA, Jose Valdez Ramalho MADRUGA, Tania REUTER, Leila Maria Moreira Beltrão PEREIRA, Giovanni Faria SILVA, Mario Reis ÁLVARES-DA-SILVA, Heverton ZAMBRINI, Paulo Roberto Abrão FERREIRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASEArquivos de Gastroenterologia 2018; 55(4): 329 doi: 10.1590/s0004-2803.201800000-74
15
Frank P. Schmidt, Tim Zimmermann, Till Wenz, Boris Schnorbus, Mir Abolfazl Ostad, Christina Feist, Annette Grambihler, Jörn M. Schattenberg, Martin F. Sprinzl, Thomas Münzel, Peter R. Galle. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionInternational Journal of Cardiology 2018; 271: 296 doi: 10.1016/j.ijcard.2018.04.058
16
Ashraf Abd El-Khalik Barakat, Fatma Mohammad Nasr, Amna Ahmed Metwaly, Sherif Morsy, Mervat Eldamarawy. Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosisThe Egyptian Heart Journal 2017; 69(2): 139 doi: 10.1016/j.ehj.2016.10.004
17
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro‐cardiovascular disease: analysis of a national population‐based survey in EgyptTropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
18
Nick Nielsen, Sofie Jespersen, Julie Gaardbo, Caroline Arnbjerg, Mette Clausen, Mette Kjær, Jan Gerstoft, Vibe Ballegaard, Sisse Ostrowski, Susanne Nielsen. Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus InfectionInternational Journal of Molecular Sciences 2017; 18(5): 1016 doi: 10.3390/ijms18051016
19
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney DiseaseAnnals of Hepatology 2017; 16(6): 851 doi: 10.5604/01.3001.0010.5275